Thyrocare Technologies Limited reported a robust 23% year-on-year revenue growth in Q1FY26. The company's core Pathology segment significantly contributed to this surge.

Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare ...

Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...

Mumbai: After years of relying on external partnerships, Sion hospital is set to expand its efforts to hunt for drug-resistant tuberculosis by adding .

Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new ...

LIC, Lupin, Divi's, 3M India, Abbott India, Fortis Healthcare, Bharti Hexacom, Union Bank, Zydus Lifesciences, Orient Cement ...

Thyrocare Technologies' shares soared 13% after reporting a 60% YoY surge in Q1 net profit, bolstered by strong operational revenue growth.

Shares of Thyrocare Technologies surged 13% to hit the day's high of Rs 1,357.85 on the NSE on Thursday following the company ...

Thyrocare Technologies surged 11.30% to Rs 1,340.55 after the healthcare service provider reported a 61.07% increase in consolidated net profit to Rs 38.93 crore on a 23.02% rise in revenue from ...

Thyrocare Technologies delivered excellent results in Q1. Both the company’s revenue and profit have increased. CEO Rahul Guha expressed optimism for faster growth in FY26. In an exclusive ...

Thyrocare Technologies shares zoomed 12.66 per cent in trade, hitting a 52-week high at ₹1,356.95 per share on the BSE.

Real-time updates on THYROCARE TECHNOLOGIES share price. Check out the detailed analysis of the company in this live blog.